November 20, 2025 · Form 4 insider transaction
Del Carmen Jeffrey bought 106,873 shares of Cameron Pharmaceutical Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028.